No Interaction Expected
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP)
Quality of Evidence:
Coadministration has not been studied but based on metabolism and clearance a clinically significant interaction is unlikely. Oxamniquine is thought to be metabolized to inactive metabolites by CYP2D6. As renal excretion of unchanged drug is minimal, there is little potential for interactions with emtricitabine and tenofovir via competition for renal elimination pathways.
View all available interactions with
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP) by clicking